Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

PYXSPYXS
15 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in PYXIS ONCOLOGY INC

CITADEL ADVISORS LLC holds 61,249 shares of PYXS (PYXIS ONCOLOGY INC), worth $89,424 as of 2026-Q1. The position was decreased (-74.9% shares).

Current Value

$89,424

Current Shares

61,249

Total Value Change

-$16.4M

Total Shares Change

-1.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Decreased
61,249
-74.9%
$89,4240.0%$1.43
0
2025-Q4
Decreased
243,589
-27.8%
$280,1270.0%$1.09
0
2025-Q3
New
337,359
-
$748,9370.0%$2.20
34
2024-Q4
Exited
0
-100.0%
$00.0%$1.56
0
2024-Q3
New
275,951
-
$1M0.0%$3.62
35
2024-Q2
Exited
0
-100.0%
$00.0%$3.31
0
2024-Q1
Decreased
4,109
-96.2%
$17,5040.0%$4.26
0
2023-Q4
New
106,835
-
$192,3030.0%$1.80
35
2023-Q2
Exited
0
-100.0%
$00.0%$2.59
0
2023-Q1
Decreased
27,129
-98.3%
$108,7870.0%$6.00
0
2022-Q4
Increased
1.6M
+2.1%
$2.1M0.0%$1.34
26
2022-Q3
Increased
1.5M
+0.7%
$3M0.0%$1.93
26
2022-Q2
Decreased
1.5M
-0.1%
$3.6M0.0%$2.35
0
2022-Q1
Increased
1.5M
+0.1%
$6.1M0.0%$4.09
27
2021-Q4
New
1.5M
-
$16.5M0.0%$10.89
39

Other major holders of PYXS: RA CAPITAL MANAGEMENT, L.P., RTW INVESTMENTS, LP, Janus Henderson Group Ltd., BALYASNY ASSET MANAGEMENT L.P., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used